BlossomHill Therapeutics, Inc. Common Stock (BLSM) is a publicly traded the market company. As of August 10, 2026, BLSM trades at $16.12 with a market cap of $465.30M and a P/E ratio of 0.00. BLSM moved +0.38% today. Year to date, BLSM is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.25 to $16.05. Rallies surfaces BLSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BlossomHill Therapeutics, Inc. Common Stock (BLSM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BLSM moved +0.38% today.
| Metric | Value |
|---|---|
| Price | $16.12 |
| Market Cap | $465.30M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.05 |
| 52-Week Low | $15.25 |
| Volume | 377.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BLSM analyst coverage data. Average price target: $0.00.